Treatment of Reperfusion Event by Vitamin C Infusion
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Primary Hypothesis: Prophylactic Vitamin C Intravenous Infusion at the time of percutaneous
coronary intervention (PCI) would limit the size of the infarct, assessed by measurements of
cardiac biomarkers, during acute myocardial infarction.
Secondary Hypotheses: Prophylactic Vitamin C Intravenous Infusion at the time of percutaneous
coronary intervention (PCI) would limit the size of the infarct, as measured by the area of
delayed hyperenhancement that was seen on cardiac magnetic resonance imaging (MRI), assessed
on day 5 after infarction, during acute myocardial infarction.